Novavax (NASDAQ:NVAX) shares fell on Tuesday after Citi started its coverage of the COVID shot maker with a Sell recommendation and a price target of $6, citing among other issues concerns over the ...

The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug ...

Provincial health officials recommend that Nova Scotians 65 years and older get a dose of Covid-19 vaccine this spring. The ...

In the real world setting, when patients have to pay for their drugs out of their own pocket and without a rigorous reminder, ...

Citi initiated coverage on small- and mid-cap biotechnology companies on early signs of improving sentiment in a sector weighed down this year by policy uncertainty and weak investor interest.

Although vaccines may have a tougher time winning the endorsement of the CDC's Advisory Committee on Immunization Practices ...

COVID-19 appears to be on the rise in some parts of California as a new, highly contagious subvariant — featuring “razor ...